Zacks lowers EndoChoice to “sell” rating: 4 notes

MarketBeat shows that Zacks lowered EndoChoice Holdings stock from a “hold” rating to a “sell” rating, according to EMQ News & Analysis.

Advertisement

Here are four notes:

1. EndoChoice Holdings has a 12-month low of $6.23 and a 12-month high of $19.69.

2. The company has a 50-day moving average of $8.17 and a 200-day moving average of $12.29.

3. The firm’s market cap is $163.65 million.

4. On average, EndoChoice Holdings has a rating of “buy” and a target price of $23.33.

More articles on GI/endoscopy:
GI physician leader to know: Dr. David Alpers of Washington University at St. Louis
Frozen vs. fresh fecal matter for FMT — Does it make a difference? 4 insights
Midwest Gastroenterology adds Dr. Richard Lozoff — 3 points

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.